Belgium Tech Debt & Growth Capital (Gimv)🎯 Single Applicant Eligible

Gimv — Gimv Smart Industries & Life Sciences PE [Tier 2 Facility]

Originally published in French or Dutch
Moderate language barrierEnglish translation available ↓

Opportunity overview

Primary debt & growth structures: Growth equity, expansion PE, structured mezzanine, buy-and-build credit. Typical borrower profile: European companies with verified clinical or industrial product-market fit and €10M+ revenue. Target stages: Series B, Series C, Late Stage Buyout.
Pro Feature

Unlock Complete Call Dossier

Read the unredacted funding guidelines, scope, eligibility criteria, and submission instructions.

Upgrade to Pro to Read Full Call →

EU Fund Portal Signals

Is this worth the team's time?

Directional signals based on the call structure, available source text, and deadline pressure. These are not funding guarantees.

Source language: French or DutchConfidence: Low

Competition

2/ 5

High Competition

5 means a narrower, more approachable field. 1 means heavy competition.

Application Effort

2/ 5

Manageable

1 is straightforward. 5 means a demanding application with heavier coordination or compliance.

Why competition looks like this

Confidence: Low
  • A large maximum award usually makes the call more attractive to many applicants.

Why effort looks like this

Confidence: Low
  • Expect a standard proposal package with budget and supporting materials.
AI Dossier Preview

Unlock Full Feasibility Intelligence & Consultant Analysis

Pro members access complete competitive breakdowns, compliance risk analyses, plain-English translations for foreign-language notices, and tailored submission checklists.

Unlock Pro Intelligence →Instant access • Cancel anytime

Consortium

Probably not required

Co-funding

Not clearly indicated

Documentation

Moderate

Deadline pressure

Moderate

Eligibility scope

Balanced

Technical depth

Low

Plain-English translation

The original call appears to be in French or Dutch. Translate the source summary and eligibility notes into concise English for faster review.

Translate with Pro Trial →

Eligibility

Series BSeries CLate Stage Buyout

Application deadline

31/12/2026
65 days remaining

Key information

Value of call
€40.0M
Sector
Healthcare
Country
BE
Funder
Gimv

Official Application Portal

Direct submission URL and issuing body documents are reserved for Pro subscribers.

Unlock Official Portal Link →
Tracked by EU Fund Portal since 29/09/2026
Last checked 26/10/2026

Preparation Checklist

Get a step-by-step preparation checklist tailored to this programme. Available on Pro.

Read the full call text
Verify eligibility
Check partnership requirements
Upgrade to Pro to unlock